277 results on '"Tai, Chun‐Hwei"'
Search Results
2. Influence of Verbal Instruction on Gait Training in Parkinson Disease: A Randomized Controlled Trial
3. Bioactive self-healing hydrogel based on tannic acid modified gold nano-crosslinker as an injectable brain implant for treating Parkinson’s disease
4. Exploring Potential Predictors of Treadmill Training Effects in People With Parkinson Disease
5. Long-Term Outcomes of Idiopathic and Acquired Dystonia After Pallidal Deep Brain Stimulation: A Case Series
6. An anti-inflammatory electroconductive hydrogel with self-healing property for the treatment of Parkinson’s disease
7. Publisher Correction: Platelet abnormalities in patients with Parkinson's disease undergoing preoperative evaluation for deep brain stimulation
8. Platelet abnormalities in patients with Parkinson's disease undergoing preoperative evaluation for deep brain stimulation
9. Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency
10. Subthalamic burst firing: A pathophysiological target in Parkinson’s disease
11. Investigating DYT1 in a Taiwanese dystonia cohort
12. Genetic analysis of IRF2BPL in a Taiwanese dystonia cohort: The genotype and phenotype correlation
13. Feasibility of Smartphone-Based Gait Assessment for Parkinson’s Disease
14. Eladocagene exuparvovec gene therapy improves motor development in patients with aromatic L-amino Acid decarboxylase deficiency
15. Exploring Potential Predictors of Treadmill Training Effects in People With Parkinson Disease
16. Blood neurofilament light chain as a surrogate marker for dystonia
17. Author Correction: Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders
18. Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders
19. Clinical heterogeneity of LRRK2 p.I2012T mutation
20. Eladocagene Exuparvovec Gene Therapy Improves Motor Development in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency (S34.004)
21. Genetic analysis of IMPDH2 gene in Taiwanese patients with isolated or combined dystonia
22. Correction to: Feasibility of Smartphone-Based Gait Assessment for Parkinson’s Disease
23. Influences of Aerobic Exercise on Motor Sequence Learning and Corticomotor Excitability in People With Parkinson’s Disease
24. Cerebellar deep brain stimulation for movement disorders
25. Neuronal firing patterns outweigh circuitry oscillations in parkinsonian motor control
26. Training in Varying Environmental Contexts Facilitates Transfer of Improved Gait Performance to New Contexts for Individuals With Parkinson Disease: A Randomized Controlled Trial
27. Pedunculopontine nucleus deep brain stimulation in Parkinsonʼs disease: A clinical review
28. Long‐term efficacy of bilateral subthalamic deep brain stimulation in the parkinsonism of SCA 3: A rare case report
29. COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition
30. Eladocagene Exuparvovec Gene Therapy Improves Motor Development in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency (S39.006)
31. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan
32. Advanced Theory of Mind in patients at early stage of Parkinson’s disease
33. A Clinical and Integrated Genetic Study of Isolated and Combined Dystonia in Taiwan
34. Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson’s disease
35. Amantadine treatment and delayed onset of levodopa‐induced dyskinesia in patients with early Parkinson's disease
36. Long-Term Outcome of Idiopathic and Acquired Dystonia After Pallidal Deep Brain Stimulation: A Case Series
37. Deranged NMDAergic cortico-subthalamic transmission underlies parkinsonian motor deficits
38. The T-type calcium channel as a new therapeutic target for Parkinson’s disease
39. DYT6 Dystonia Mimicking Adolescent Idiopathic Scoliosis Successfully Treated by Pallidal Stimulation
40. Improved Motor Function in Children with AADC Deficiency Treated with Eladocagene Exuparvovec (PTC-AADC): Interim Findings from a Phase 2 Trial
41. 390 Efficacy of gene therapy with eladocagene exuparvovec in patients with AADC deficiency compared with natural history controls
42. Reliability of using foot-worn devices to measure gait parameters in people with Parkinson’s disease
43. Eye‐of‐Tiger Sign in Globus Pallidus: A Novel Radiological Feature of Spinocerebellar Ataxia Type 28
44. Novel variant Pro143Ala in HTRA2 contributes to Parkinson’s disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria
45. Modulation of subthalamic T-type [Ca.sup.2+] channels remedies locomotor deficits in a rat model of Parkinson disease
46. Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations
47. LRRK2 mutation in familial Parkinson’s disease in a Taiwanese population: clinical, PET, and functional studies
48. Improved Motor Function in Children With Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Treated With Eladocagene Exuparvovec (PTC-AADC): Interim Findings From a Phase 1/2 Study (2057)
49. Improved Motor Function in Children With Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Treated With Eladocagene Exuparvovec (PTC-AADC): Interim Findings From a Phase 2 Trial (2366)
50. Improved Motor Function in Children With Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Treated With Eladocagene Exuparvovec (PTC-AADC): Compassionate Use Study (2387)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.